Institutional investors control 12.76% of the outstanding shares in GSK. This represents a greater percentage of ownership than at almost any other company in the Pharmaceuticals: Major industry. Additionally, during the quarter ended June 2019, these large investors purchased a net $15.2 million shares.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
DODGE & COX Bought 25.0 Million shares of GlaxoSmithKline PLC
UBS SECURITIES LLC Bought 7.0 Million shares of GlaxoSmithKline PLC
NOMURA SECURITIES CO., LTD. (PRI... Bought 3.4 Million shares of GlaxoSmithKline PLC